2018-2023 Global Peptic Ulcer Drugs Consumption Market Report

August 2018 | 133 pages | ID: 2AAB0FB142AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Peptic Ulcer Drugs market for 2018-2023.

Drug treatment of peptic ulcers is targeted at either counteracting aggressive factors or stimulating the mucosal defense.
Drugs that inhibit or neutralize gastric acid secretion include histamine H2-receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandins and antacids.
Over the next five years, LPI(LP Information) projects that Peptic Ulcer Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptic Ulcer Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Proton Pump Inhibitors
• Potassium-Competitive Acid Blockers
• Antacids
• H2-Antagonists
• Antibiotics
• Ulcer Protective Drugs

Segmentation by application:

• Hospital Pharmacies
• Private Clinics
• Drug Stores
• Retail Pharmacies
• E-Commerce

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Daewoong Pharmaceutical
• Takeda Pharmaceutical
• Pfizer
• Abbott Laboratories
• AstraZeneca
• Cadila Healthcare
• Boehringer Ingelheim
• Eisai
• Yuhan
• GlaxoSmithKline Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Peptic Ulcer Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Peptic Ulcer Drugs market by identifying its various subsegments.
• Focuses on the key global Peptic Ulcer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Peptic Ulcer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Peptic Ulcer Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peptic Ulcer Drugs Consumption 2013-2023
  2.1.2 Peptic Ulcer Drugs Consumption CAGR by Region
2.2 Peptic Ulcer Drugs Segment by Type
  2.2.1 Proton Pump Inhibitors
  2.2.2 Potassium-Competitive Acid Blockers
  2.2.3 Antacids
  2.2.4 H2-Antagonists
  2.2.5 Antibiotics
  2.2.6 Ulcer Protective Drugs
2.3 Peptic Ulcer Drugs Consumption by Type
  2.3.1 Global Peptic Ulcer Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Peptic Ulcer Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Peptic Ulcer Drugs Sale Price by Type (2013-2018)
2.4 Peptic Ulcer Drugs Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Private Clinics
  2.4.3 Drug Stores
  2.4.4 Retail Pharmacies
  2.4.5 E-Commerce
2.5 Peptic Ulcer Drugs Consumption by Application
  2.5.1 Global Peptic Ulcer Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Peptic Ulcer Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Peptic Ulcer Drugs Sale Price by Application (2013-2018)

3 GLOBAL PEPTIC ULCER DRUGS BY PLAYERS

3.1 Global Peptic Ulcer Drugs Sales Market Share by Players
  3.1.1 Global Peptic Ulcer Drugs Sales by Players (2016-2018)
  3.1.2 Global Peptic Ulcer Drugs Sales Market Share by Players (2016-2018)
3.2 Global Peptic Ulcer Drugs Revenue Market Share by Players
  3.2.1 Global Peptic Ulcer Drugs Revenue by Players (2016-2018)
  3.2.2 Global Peptic Ulcer Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Peptic Ulcer Drugs Sale Price by Players
3.4 Global Peptic Ulcer Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Peptic Ulcer Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Peptic Ulcer Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PEPTIC ULCER DRUGS BY REGIONS

4.1 Peptic Ulcer Drugs by Regions
  4.1.1 Global Peptic Ulcer Drugs Consumption by Regions
  4.1.2 Global Peptic Ulcer Drugs Value by Regions
4.2 Americas Peptic Ulcer Drugs Consumption Growth
4.3 APAC Peptic Ulcer Drugs Consumption Growth
4.4 Europe Peptic Ulcer Drugs Consumption Growth
4.5 Middle East & Africa Peptic Ulcer Drugs Consumption Growth

5 AMERICAS

5.1 Americas Peptic Ulcer Drugs Consumption by Countries
  5.1.1 Americas Peptic Ulcer Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Peptic Ulcer Drugs Value by Countries (2013-2018)
5.2 Americas Peptic Ulcer Drugs Consumption by Type
5.3 Americas Peptic Ulcer Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Peptic Ulcer Drugs Consumption by Countries
  6.1.1 APAC Peptic Ulcer Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Peptic Ulcer Drugs Value by Countries (2013-2018)
6.2 APAC Peptic Ulcer Drugs Consumption by Type
6.3 APAC Peptic Ulcer Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Peptic Ulcer Drugs by Countries
  7.1.1 Europe Peptic Ulcer Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Peptic Ulcer Drugs Value by Countries (2013-2018)
7.2 Europe Peptic Ulcer Drugs Consumption by Type
7.3 Europe Peptic Ulcer Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peptic Ulcer Drugs by Countries
  8.1.1 Middle East & Africa Peptic Ulcer Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Peptic Ulcer Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Peptic Ulcer Drugs Consumption by Type
8.3 Middle East & Africa Peptic Ulcer Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Peptic Ulcer Drugs Distributors
10.3 Peptic Ulcer Drugs Customer

11 GLOBAL PEPTIC ULCER DRUGS MARKET FORECAST

11.1 Global Peptic Ulcer Drugs Consumption Forecast (2018-2023)
11.2 Global Peptic Ulcer Drugs Forecast by Regions
  11.2.1 Global Peptic Ulcer Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Peptic Ulcer Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Peptic Ulcer Drugs Forecast by Type
11.8 Global Peptic Ulcer Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Daewoong Pharmaceutical
  12.1.1 Company Details
  12.1.2 Peptic Ulcer Drugs Product Offered
  12.1.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Daewoong Pharmaceutical News
12.2 Takeda Pharmaceutical
  12.2.1 Company Details
  12.2.2 Peptic Ulcer Drugs Product Offered
  12.2.3 Takeda Pharmaceutical Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Takeda Pharmaceutical News
12.3 Pfizer
  12.3.1 Company Details
  12.3.2 Peptic Ulcer Drugs Product Offered
  12.3.3 Pfizer Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pfizer News
12.4 Abbott Laboratories
  12.4.1 Company Details
  12.4.2 Peptic Ulcer Drugs Product Offered
  12.4.3 Abbott Laboratories Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Abbott Laboratories News
12.5 AstraZeneca
  12.5.1 Company Details
  12.5.2 Peptic Ulcer Drugs Product Offered
  12.5.3 AstraZeneca Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 AstraZeneca News
12.6 Cadila Healthcare
  12.6.1 Company Details
  12.6.2 Peptic Ulcer Drugs Product Offered
  12.6.3 Cadila Healthcare Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Cadila Healthcare News
12.7 Boehringer Ingelheim
  12.7.1 Company Details
  12.7.2 Peptic Ulcer Drugs Product Offered
  12.7.3 Boehringer Ingelheim Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Boehringer Ingelheim News
12.8 Eisai
  12.8.1 Company Details
  12.8.2 Peptic Ulcer Drugs Product Offered
  12.8.3 Eisai Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Eisai News
12.9 Yuhan
  12.9.1 Company Details
  12.9.2 Peptic Ulcer Drugs Product Offered
  12.9.3 Yuhan Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Yuhan News
12.10 GlaxoSmithKline Pharmaceuticals
  12.10.1 Company Details
  12.10.2 Peptic Ulcer Drugs Product Offered
  12.10.3 GlaxoSmithKline Pharmaceuticals Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 GlaxoSmithKline Pharmaceuticals News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Peptic Ulcer Drugs
Table Product Specifications of Peptic Ulcer Drugs
Figure Peptic Ulcer Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Peptic